- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Medical Products
Snapshot for Carmat (CXT)
| Open: | 125.654 | Day's Range: | 122.079 - 126.064 | Volume: | 102 |
|---|---|---|---|---|---|
| Previous Close: | 126.213 | 52wk Range: | 90.297 - 137.960 | 1-Yr Rtn: | +34.35% |
Key Statistics for CXT
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (EUR) (ttm) | - |
| Est. EPS (EUR) (12/2013) | -3.6400 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 31 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/17/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CXT
Company Profile & Key Executives for CXT
Carmat is medical technology start-up company. The Company intends to market a fully implantable artificial heart for patients suffering in the aftermath of a heart attack or with late-stage heart failure and for whom standard drug therapy, ventricular assistance and/or a heart transplant have failed or are not possible.
| Jean-Claude CadudalChairman | Marcello ConvitiChief Executive Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CXT News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page